Jan 28 (Reuters) - U.S. President Donald Trump plans to
impose tariffs on imported computer chips, pharmaceuticals and
steel, he said on Monday, to push companies to manufacture more
in the United States.
The comments mark the latest in a number of trade-related
threats unleashed by Trump in recent days. He has already
promised to slap 25% tariffs on imports from Canada and Mexico
by Feb. 1 if the two countries don't meet demands on border
security and other issues.
By focusing on chips and pharmaceuticals, Trump could
squeeze U.S. allies in Asia, including Taiwan, South Korea and
Japan.
WHAT'S BEING TARGETED FOR CHIPS?
Trump said he plans to impose tariffs on imported computer
chips without providing details.
Asia is the world's biggest chip manufacturing hub,
producing more than 80% of semiconductors sold globally,
according to the Asian Development Bank.
Taiwan Semiconductor Manufacturing Co. ( TSM ) , the
world's largest contract chipmaker, makes semiconductors for
Nvidia ( NVDA ), Apple and other U.S. clients. TSMC generated 70% of its
revenue in 2024 from customers based in North America.
While it is building a $65 billion manufacturing facility in
Arizona, the bulk of TSMC's production remains in Taiwan, with
exports to the U.S. theoretically subject to tariffs.
WHAT ABOUT OTHER CHIPS?
Asian producers also dominate the market for memory chips,
with DRAM and NAND flash chips used in electronic devices
including computers.
South Korea's Samsung Electronics ( SSNLF ) and SK Hynix ( HXSCF )
together control around three quarters of the global
DRAM market.
The two companies, plus Japan's Kioxia, which is controlled
by U.S. buyout firm Bain Capital, command a similar market share
in NAND flash.
Samsung is investing roughly $44 billion in chipmaking
facilities in Texas with subsidies from the U.S. government.
WHAT ABOUT THE ECONOMIC HIT?
Chips are a major source of export revenue for South Korea
and Taiwan, meaning there's a lot more at stake than just the
impact on manufacturers themselves.
South Korea's exports of semiconductors hit a record $141.9
billion in 2024, of which $10.28 billion was to the U.S.,
according to data released by the Ministry of Trade, Industry
and Energy earlier this month.
WHAT ABOUT OTHER CHIP SUPPLY CHAIN COMPANIES?
Japan is a major supplier of chipmaking equipment and
materials, all of which, at least for now, appear to have
avoided direct mention by Trump. Major equipment companies
include Tokyo Electron ( TOELF ) and Advantest ( ADTTF ).
WHAT ABOUT PHARMA?
Imposing tariffs on imported pharmaceuticals could weigh on
Japan, home of major drugmakers such as Takeda, Astellas,
Daiichi Sankyo ( DSKYF ) and Eisai ( ESALF ), which has been expecting strong sales
growth in the U.S. of its Alzheimer's disease drug Leqembi.
For Takeda, the U.S. market accounted for just over half of
its revenue in last financial year, while for Astellas it
accounted for 41%. In both cases it wasn't clear how much of the
U.S. revenue came from imports.
In a statement, Astellas said it was always preparing for
geopolitical risks to ensure a stable supply of products. It
also said it had invested in multiple manufacturing sites in the
U.S. and would continue to do so.